Tier 2 · Liquid 3000
Stoke Therapeutics, Inc.
STOK · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$32.32
+0.00%
Coverage
Tier 2
Tier 2 · Liquid 3000
SEC CIK
0001623526
Liquidity rank
#2101
Observed dollar volume
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | $184.42M | 2025-12-31 | 0001193125-26-108362 |
| Annual diluted EPS | -0.12 | 2025-12-31 | 0001193125-26-108362 |
| Quarterly revenue | $9.33M | 2026-06-30 | 0001193125-26-330557 |
| Quarterly diluted EPS | -0.93 | 2026-06-30 | 0001193125-26-330557 |
SEC EDGAR Frames batch generated 2026-08-24T22:57:10.564Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Dividends
Trailing 12 months
Not published
Latest payment
Not published
Yahoo Finance corporate actions. Window: 2025-08-25 through 2026-08-25.
Seasonality
| Month | Mean return | Positive | n |
|---|
Monthly close-to-close returns, trailing 15 years where Yahoo history is available.
Sector news
No matching sector headlines were returned in the 72-hour window.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerISRG · Tier 1 peerPFE · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames